Quality Choice Simethicone Gas Relief 100 Chewable Tablets

Manufacturer
QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)
Effective date
2026-10-29
Label type
HUMAN OTC DRUG LABEL
Version
7
Source
daily-update
Hydrated at
2026-11-03 06:09:35

Label at a glance#

ProductQC Gas Relief Mint Flavor
Active ingredientDIMETHICONE, UNSPECIFIED
Label structure8 sections

Indications and uses

Relieves: ▪ bloating ▪ pressure ▪ fullness ▪ stuffed feeling 

Dosage and administration

▪ thoroughly chew 1 to 2 tablets as needed after meals and at bedtime ▪ do not exceed 6 tablets per day unless directed by a doctor

Storage and handling

▪ store at room temperature avoid high humidity and excessive heat, above 40ºC (104ºF) ▪ do not use if inner seal is broken or missing ▪ each tablets contains: calcium 60mg

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Simethicone 80 mg

Purpose

OTC - PURPOSE SECTION

Antigas

Uses

INDICATIONS & USAGE SECTION

Relieves:

  • bloating
  • pressure
  • fullness
  • stuffed feeling 

Warnings

WARNINGS SECTION

Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center immediately.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Directions

DOSAGE & ADMINISTRATION SECTION

  • thoroughly chew 1 to 2 tablets as needed after meals and at bedtime
  • do not exceed 6 tablets per day unless directed by a doctor

Other information

STORAGE AND HANDLING SECTION

  • store at room temperature avoid high humidity and excessive heat, above 40ºC (104ºF)
  • do not use if inner seal is broken or missing
  • each tablets contains: calcium 60mg

Inactive ingredients

INACTIVE INGREDIENT SECTION

dextrose, peppermint flavor, maltodextrin, microcrystalline cellulose, silica, tribasic calcium phosphate

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 63868-108-01

QUALITY CHOICE®

*Compare to the Mylanta® Gas Active Ingredient

Gas Relief

Anti Gas
Simethicone 80 mg

Relieves:
Pressure

Bloating &

Discomfort

Mint Flavor

100 CHEWABLE TABLETS

QC SATISFACTION GURANTEED

Distributed by C.D.M.A., Inc.

43157 W. Nine Mile

Novi, MI 48376-0995

www.qualitychoice.com

Questions: 248-449-9300

This product is not manufactured or distributed by JOHNSON & JOHNSON MERCK Consumer Pharmaceuticals Co., the distributed of MYLANTA® GAS

Quality Choice Simethicone 100 Chewable Tablets
Quality Choice Simethicone 100 Chewable Tablets

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130635515946354GTIN-13: 0635515946354
EAN-13: 0635515946354
GTIN-12: 635515946354
UPC-A: 635515946354
GTIN storage (14 digits): 00635515946354
leader-44-137-1.jpg

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63868-10863868-108-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
62025-12-03full-release2026-06-01 01:19:15

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
QC Gas Relief Mint FlavorSIMETHICONEQUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)26b83259-744b-4711-a32f-9f8fe5d0555b2026-10-29WarningsExact identifier
ndc (package): 63868-108-01
ndc (product): 63868-108
ndc11 (package): 63868010801
spl id: 74b28e48-66bb-403d-8289-282aeb0d5e4f
spl set id: 26b83259-744b-4711-a32f-9f8fe5d0555b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.